Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

1156 POSTS

Exclusive articles:

SKN | NexMetals Mining (NEXM) Gains Attention as Nickel-Copper Focus Aligns With Critical Metals Demand

NexMetals Mining Corp. (Nasdaq: NEXM) is drawing renewed investor interest as its shares trend higher amid growing global demand for critical battery and industrial...

SKN | Fleet Management Software Provider Motive Technologies Files for a $100 Million IPO

Motive Technologies, a leading provider of fleet management software solutions, has filed for a $100 million initial public offering in the United States, aiming...

SKN | China-Based Copper Industrial Components Manufacturer AOJE Files for a $30 Million US IPO

AOJE, a China-based manufacturer of copper industrial components, has filed for a $30 million initial public offering in the United States, signaling its intent...

SKN | Hong Kong Student Dorm Provider Student Living EduVation Files for a $29 Million US IPO

Student Living EduVation, a Hong Kong-based operator of student dormitories, has filed for a $29 million initial public offering in the United States, targeting...

SKN | SPAC Silicon Valley Acquisition Prices $200 Million IPO, Targeting Sectors Undergoing Structural Transformation

Silicon Valley Acquisition has priced its initial public offering at $10 per unit, raising $200 million as it enters the U.S. stock market as...

Breaking

SKN | American Century Investments Launches Emerging Markets Insights ETF on Nasdaq

Key Points: American Century Investments has launched the Emerging...

SKN | ETF Launches and Hilton’s Nasdaq Transfer Shape November 5 Listings

Key Takeaways: The November 5 IPO calendar listed five...

SKN | American Ventures Acquisition I Cuts Proposed IPO Size by 25% to $75 Million

American Ventures Acquisition I, a blank check company targeting...

SKN | Rezera Sets Terms for $200 Million IPO as GSK Signals Up to $25 Million Investment

Rezera, a clinical-stage biotechnology company developing oral NLRP3 inhibitors...
spot_imgspot_img